Clinical Trials Logo

Preterm Infant clinical trials

View clinical trials related to Preterm Infant.

Filter by:

NCT ID: NCT03731611 Completed - Preterm Infant Clinical Trials

Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

To investigate the effect of umbilical cord milking (UCM) on peripheral hematologic parameters including hematopoietic progenitor cells in premature infants ≤ 34 weeks gestational age with placental insufficiency. We hypothesize that UCM would enhance peripheral CD34 concentration, hemoglobin and reduce prematurity complications like NEC and IVH in preterm infant ≤ 34 week gestational age with placental insufficiency.

NCT ID: NCT03731546 Completed - Preterm Infant Clinical Trials

Effect of Delayed Cord Clamping in Preterm Neonates With Placental Insufficiency

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

To investigate the effect of delayed cord clamping (DCC) on hematopoietic progenitor cells (HPCs), hematological parameters including haemoglobin concentration and hematocrit value in premature infants (34 weeks gestational age or less) with placental insufficiency.We hypothesized that preterm infants with placental insufficiency underwent DDC could have better hematologic parameters and hematopoietic progenitor cells compared to immediate cord clamping.

NCT ID: NCT03728764 Completed - Preterm Infant Clinical Trials

Growth and Safety of a Two-stage Feeding System in Preterm Infants

Start date: October 10, 2018
Phase: N/A
Study type: Interventional

This study evaluates the safety and suitability of the two-stage feeding system in preterm infants.

NCT ID: NCT03721640 Completed - Preterm Infant Clinical Trials

Evaluation of the Neonatal Autonomic Stress During Intubations Under Propofol in a Population of Premature Infants Under 33 w'GA

PROPOSURF
Start date: February 25, 2019
Phase:
Study type: Observational

Hyaline membrane disease is one of the leading causes of morbidity and mortality in premature newborns in industrialized countries. For 30 years, the management of the hyaline membranes disease has been transformed by intratracheal administration of exogenous surfactant (Curosurf®) at birth or in the following hours. In order to limit the harmful effects in terms of barotrauma of mechanical ventilation, several methods have been developed over the last decades, aiming at limiting the mechanical ventilation to the profile of non-invasive ventilation: Thus the administration of surfactant has become faster (although invasive) and if possible followed by immediate extubation following the INSURE (INtubation / SURfactant / Extubation) or LISA (Less-Invasive Surfactant Administration) procedure. Given the fragility of the children concerned and their low weight, this invasive gesture has long been carried out without premedication. However, taking into account the pain induced and potential hemodynamic consequences of the gesture, neonatal societies now recommend the use of anesthetic before intubation, with a short duration sedative. Propofol is a general anesthetic that combines these conditions and is widely used in pediatric anesthesia. In that way, since 2016, the invetigators have modified the sedation protocol for intubation in our department and have recommended Propofol as first-line treatment for term and preterm newborn. A lot of study showed its hemodynamic safety in preterms. However, the investigators lack data on the autonomic stress really observed during intubation in this population. The investigators therefore propose to evaluate these physiological data in a non-randomized prospective observational study in premature infants under 33 weeks of gestational amenorrhea (GA), during a sedation protocol for intubation and surfactant administration according the INSURE or LISA technique, with standardized doses of propofol : 1mg/kg for preterm infants with a birthweight less than 1.5kg and 1.5mg/kg for higher birthweight.

NCT ID: NCT03704012 Completed - Premature Birth Clinical Trials

Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas)

PreMas
Start date: September 1, 2012
Phase: N/A
Study type: Interventional

The purpose of this study was to analyze the efficacy of massage therapy and kinesiotherapy, applied by the parents of hospitalized preterm infants, in the improvement of the biological state, neuromotor activity and other associated factors.

NCT ID: NCT03701074 Terminated - Clinical trials for Bronchopulmonary Dysplasia

Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus

Start date: December 15, 2018
Phase: Phase 2
Study type: Interventional

The purpose of the present study is to determine whether treatment of hemodynamically significant patent ductus arteriosus with a combined therapy of intravenous Ibuprofen and oral acetaminophen has higher success rate in closing the ductus arteriosus than a standard treatment strategy of using intravenous ibuprofen alone among preterm infants.

NCT ID: NCT03700619 Completed - Preterm Infant Clinical Trials

Executive Functions and Preterm Children in 11 to 12 Year Old

Start date: January 30, 2019
Phase:
Study type: Observational

Preterm children have a high risk for neurodevelopmental impairments. The impact on motor functions and neurosensory functions is demonstrated but the incidence of executive functions is not described for preterm infants.

NCT ID: NCT03700463 Completed - Preterm Infant Clinical Trials

Executive Functions and Preterm Children in 3 to 4 Year Old

Start date: October 16, 2018
Phase:
Study type: Observational [Patient Registry]

Preterm children have a high risk for neurodevelopmental impairments. The impact on motor functions and neurosensory functions is demonstrated but the incidenceof executive functions is not described for preterm infants.

NCT ID: NCT03694613 Completed - Preterm Infant Clinical Trials

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the utility of placental/umbilical cord blood (PUCB) to perform the baseline workup testing for EONS in Very Low Birth Weight Infants: CBC (Complete Blood Count) with differential, Immature/Total ratio (I/T ratio), and blood culture along with CRP and IL-6 levels. A cohort (63 subjects) of preterm infants will be recruited. All the participants will be evaluated for sepsis using placental/umbilical cord blood (PUCB) and subject blood sample during the first 12 hours of life (after birth).

NCT ID: NCT03677752 Completed - Child Development Clinical Trials

GP_Posit Intervention for Mothers of Preterm Infants for Maternal Sensitivity : Randomized Pilot Trial

GP_Posit
Start date: August 20, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the acceptability, feasibility and preliminary effects a GP_Posit intervention. GP_Posit is an intervention where mothers will learn how to participated in their preterm infant's care and positioning while being guided by a nurse. Preliminary effects will be estimated on maternal sensitivity, stress and anxiety as well as preterm infant's neurodevelopment.